About Aurore Life Sciences Private Limited
Data last updated: 22 December 2025
Aurore Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Hydra Active Pharma Sciences Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 26 September 2016, the company has been in operation for over 10 years.
Registered with ROC Mumbai under CIN U74999MH2016PTC371990.
Capital: an authorised share capital of ₹174 Cr and a paid-up capital of ₹116.58 Cr. It is led by directors including Rajender Juvvadi Rao and Pudhucode Radhakrishnan Kannan.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: First Floor Fine Mansion 203 D.N. Road Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹471.23 Cr, a growth of 5% compared to the previous year.
The company has a workforce of approximately 437 employees as per the latest available data. It operates as a subsidiary of Hydra Active Pharma Sciences Private Limited. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Aurore Life Sciences. As per MCA filings, the company has open charges of ₹953.13 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aurorels.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressFirst Floor Fine Mansion 203 D.N. Road Fort, Mumbai, Maharashtra, India – 400001
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited has one previous CIN (Corporate Identification Number): U74999TG2016PTC112170. The current CIN is U74999MH2016PTC371990, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999MH2016PTC371990 | Current |
| U74999TG2016PTC112170 | Previous |
Associated Brands with Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited operates one associated brand: Aurore Life Sciences. These brands represent Aurore Life Sciences Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Develops and produces Active Pharmaceutical Ingredients and intermediates for pharmaceutical markets. | aurorels.com |
Competitors & Alternatives of Aurore Life Sciences Private Limited
Brands and companies operating in the same space as Aurore Life Sciences Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Aurore Life Sciences Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited is audited by Laxminiwas&Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Laxminiwas&Co | Locked | Locked | Locked |
Complete auditor history for Aurore Life Sciences Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited is currently managed by 4 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajender Juvvadi Rao | Managing Director | 15 Jun 2017 | 9 Years 2 Months | Current |
|
Pudhucode Radhakrishnan Kannan
Also directs:
Dvise Medtech Private Limited, Serovia Pharma Private Limited, Dvise Pharma Tech Private Limited and 4 more
|
Additional Director | 13 Jan 2025 | 1 Years 7 Months | Current |
|
Dilip Murthy Buddha
Also directs:
Meraki Synergies Llp
|
Nominee Director | 01 Oct 2025 | 0 Years 10 Months | Current |
| Suresh Mudhunuri | Nominee Director | 01 Oct 2025 | 0 Years 10 Months | Current |
Financials of Aurore Life Sciences Private Limited FY 2024 filings available
Aurore Life Sciences Private Limited reported revenue of ₹471.23 Cr (up 5.00% YoY) for FY 2025.
Ten-year financial statements for Aurore Life Sciences Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aurore Life Sciences Private Limited
Shareholding and ownership data for Aurore Life Sciences Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Aurore Life Sciences Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Empyrean Lifesciences Private Limited | U24232MH2014PTC367624 | Locked |
| Aurore Pharmaceuticals Private Limited | U24239TG2017PTC117032 | Locked |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Aurore Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2025 | Others | ₹50 Cr | Open |
| 25 Apr 2025 | Yes Bank Limited | ₹50 Cr | Open |
| 27 Sep 2024 | Others | ₹300 Cr | Open |
| 28 Feb 2023 | Tata Capital Financial Services Limited | ₹60 Cr | Open |
| 09 Dec 2022 | Others | ₹18 Cr | Open |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited has a workforce of 437 employees as of Apr 08, 2024.
Employee and EPFO history for Aurore Life Sciences Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aurore Life Sciences Private Limited
GST registrations and filing compliance for Aurore Life Sciences Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aurore Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts for Aurore Life Sciences Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aurore Life Sciences Private Limited
MSME payment history for Aurore Life Sciences Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aurore Life Sciences Private Limited
Corporate group structure for Aurore Life Sciences Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aurore Life Sciences Private Limited
MCA filings and documents for Aurore Life Sciences Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aurore Life Sciences Private Limited
Frequently Asked Questions about Aurore Life Sciences Private Limited
Aurore Life Sciences Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 26 September 2016 (10+ years old) and is registered under CIN U74999MH2016PTC371990. The company has 437 employees.
Aurore Life Sciences Private Limited reported revenue of ₹471.23 Cr for FY 2025 (up 5.00% YoY).
The current directors of Aurore Life Sciences Private Limited are:
- Rajender Juvvadi Rao - Managing Director
- Pudhucode Radhakrishnan Kannan - Additional Director
- Dilip Murthy Buddha - Nominee Director
- Suresh Mudhunuri - Nominee Director
The primary industry of Aurore Life Sciences Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Aurore Life Sciences Private Limited can be reached at the registered office: First Floor Fine Mansion 203 D.N. Road Fort, Mumbai, Maharashtra, India – 400001, or through the website aurorels.com.
The authorised capital is ₹174 Cr, and the paid-up capital is ₹116.58 Cr.